ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mammalian CDMO Service Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-10Q17034
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mammalian CDMO Service Market Research Report 2024
BUY CHAPTERS

Global Mammalian CDMO Service Market Research Report 2024

Code: QYRE-Auto-10Q17034
Report
April 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
SAMSUNG
GTP
Cytovance Biologics
3P Bio
AGC Biologics
KBI Biopharma
GTP Bioways
Samsung Biologics
Wuxi Biologics
plantform corporation
Gedeon Richter
Lonza
Novartis
Rentschler Biopharma SE
Northway Biotech
Boehringer Ingelheim
Cambrex
FUJIFILM Diosynth Biotechnologies
GBI
Scorpius BioManufacturing
Tanvex CDMO

Mammalian CDMO Service Market

The global Mammalian CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mammalian CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mammalian CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Mammalian CDMO Service in Contract Research Organizations (CROs) is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Mammalian CDMO Service include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mammalian CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mammalian CDMO Service.
The Mammalian CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mammalian CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mammalian CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mammalian CDMO Service Market Report

Report Metric Details
Report Name Mammalian CDMO Service Market
Segment by Type
  • Cell Line Development
  • Genomic Analysis
  • Process Development
  • Analytical Services
  • Formulation Development
  • Manufacturing
  • Others
Segment by Application
  • Contract Research Organizations (CROs)
  • Pharmaceutical
  • Biotechnology Companies
  • Government Agencies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, Lonza, Novartis, Rentschler Biopharma SE, Northway Biotech, Boehringer Ingelheim, Cambrex, FUJIFILM Diosynth Biotechnologies, GBI, Scorpius BioManufacturing
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Mammalian CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mammalian CDMO Service Market report?

Ans: The main players in the Mammalian CDMO Service Market are Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, Lonza, Novartis, Rentschler Biopharma SE, Northway Biotech, Boehringer Ingelheim, Cambrex, FUJIFILM Diosynth Biotechnologies, GBI, Scorpius BioManufacturing

What are the Application segmentation covered in the Mammalian CDMO Service Market report?

Ans: The Applications covered in the Mammalian CDMO Service Market report are Contract Research Organizations (CROs), Pharmaceutical, Biotechnology Companies, Government Agencies, Others

What are the Type segmentation covered in the Mammalian CDMO Service Market report?

Ans: The Types covered in the Mammalian CDMO Service Market report are Cell Line Development, Genomic Analysis, Process Development, Analytical Services, Formulation Development, Manufacturing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Line Development
1.2.3 Genomic Analysis
1.2.4 Process Development
1.2.5 Analytical Services
1.2.6 Formulation Development
1.2.7 Manufacturing
1.2.8 Others
1.3 Market by Application
1.3.1 Global Mammalian CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Contract Research Organizations (CROs)
1.3.3 Pharmaceutical
1.3.4 Biotechnology Companies
1.3.5 Government Agencies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian CDMO Service Market Perspective (2019-2030)
2.2 Global Mammalian CDMO Service Growth Trends by Region
2.2.1 Global Mammalian CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mammalian CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Mammalian CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Mammalian CDMO Service Market Dynamics
2.3.1 Mammalian CDMO Service Industry Trends
2.3.2 Mammalian CDMO Service Market Drivers
2.3.3 Mammalian CDMO Service Market Challenges
2.3.4 Mammalian CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian CDMO Service Players by Revenue
3.1.1 Global Top Mammalian CDMO Service Players by Revenue (2019-2024)
3.1.2 Global Mammalian CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Mammalian CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Mammalian CDMO Service Revenue
3.4 Global Mammalian CDMO Service Market Concentration Ratio
3.4.1 Global Mammalian CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian CDMO Service Revenue in 2023
3.5 Global Key Players of Mammalian CDMO Service Head office and Area Served
3.6 Global Key Players of Mammalian CDMO Service, Product and Application
3.7 Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian CDMO Service Breakdown Data by Type
4.1 Global Mammalian CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Mammalian CDMO Service Forecasted Market Size by Type (2025-2030)
5 Mammalian CDMO Service Breakdown Data by Application
5.1 Global Mammalian CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Mammalian CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mammalian CDMO Service Market Size (2019-2030)
6.2 North America Mammalian CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mammalian CDMO Service Market Size by Country (2019-2024)
6.4 North America Mammalian CDMO Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mammalian CDMO Service Market Size (2019-2030)
7.2 Europe Mammalian CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mammalian CDMO Service Market Size by Country (2019-2024)
7.4 Europe Mammalian CDMO Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian CDMO Service Market Size (2019-2030)
8.2 Asia-Pacific Mammalian CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mammalian CDMO Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Mammalian CDMO Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mammalian CDMO Service Market Size (2019-2030)
9.2 Latin America Mammalian CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mammalian CDMO Service Market Size by Country (2019-2024)
9.4 Latin America Mammalian CDMO Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian CDMO Service Market Size (2019-2030)
10.2 Middle East & Africa Mammalian CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mammalian CDMO Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Mammalian CDMO Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytovance Biologics
11.1.1 Cytovance Biologics Company Details
11.1.2 Cytovance Biologics Business Overview
11.1.3 Cytovance Biologics Mammalian CDMO Service Introduction
11.1.4 Cytovance Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.1.5 Cytovance Biologics Recent Development
11.2 3P Bio
11.2.1 3P Bio Company Details
11.2.2 3P Bio Business Overview
11.2.3 3P Bio Mammalian CDMO Service Introduction
11.2.4 3P Bio Revenue in Mammalian CDMO Service Business (2019-2024)
11.2.5 3P Bio Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Details
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics Mammalian CDMO Service Introduction
11.3.4 AGC Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.3.5 AGC Biologics Recent Development
11.4 KBI Biopharma
11.4.1 KBI Biopharma Company Details
11.4.2 KBI Biopharma Business Overview
11.4.3 KBI Biopharma Mammalian CDMO Service Introduction
11.4.4 KBI Biopharma Revenue in Mammalian CDMO Service Business (2019-2024)
11.4.5 KBI Biopharma Recent Development
11.5 GTP Bioways
11.5.1 GTP Bioways Company Details
11.5.2 GTP Bioways Business Overview
11.5.3 GTP Bioways Mammalian CDMO Service Introduction
11.5.4 GTP Bioways Revenue in Mammalian CDMO Service Business (2019-2024)
11.5.5 GTP Bioways Recent Development
11.6 Tanvex CDMO
11.6.1 Tanvex CDMO Company Details
11.6.2 Tanvex CDMO Business Overview
11.6.3 Tanvex CDMO Mammalian CDMO Service Introduction
11.6.4 Tanvex CDMO Revenue in Mammalian CDMO Service Business (2019-2024)
11.6.5 Tanvex CDMO Recent Development
11.7 Samsung Biologics
11.7.1 Samsung Biologics Company Details
11.7.2 Samsung Biologics Business Overview
11.7.3 Samsung Biologics Mammalian CDMO Service Introduction
11.7.4 Samsung Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.7.5 Samsung Biologics Recent Development
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Details
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics Mammalian CDMO Service Introduction
11.8.4 WuXi Biologics Revenue in Mammalian CDMO Service Business (2019-2024)
11.8.5 WuXi Biologics Recent Development
11.9 PlantForm Corporation
11.9.1 PlantForm Corporation Company Details
11.9.2 PlantForm Corporation Business Overview
11.9.3 PlantForm Corporation Mammalian CDMO Service Introduction
11.9.4 PlantForm Corporation Revenue in Mammalian CDMO Service Business (2019-2024)
11.9.5 PlantForm Corporation Recent Development
11.10 Gedeon Richter
11.10.1 Gedeon Richter Company Details
11.10.2 Gedeon Richter Business Overview
11.10.3 Gedeon Richter Mammalian CDMO Service Introduction
11.10.4 Gedeon Richter Revenue in Mammalian CDMO Service Business (2019-2024)
11.10.5 Gedeon Richter Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Mammalian CDMO Service Introduction
11.11.4 Lonza Revenue in Mammalian CDMO Service Business (2019-2024)
11.11.5 Lonza Recent Development
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Mammalian CDMO Service Introduction
11.12.4 Novartis Revenue in Mammalian CDMO Service Business (2019-2024)
11.12.5 Novartis Recent Development
11.13 Rentschler Biopharma SE
11.13.1 Rentschler Biopharma SE Company Details
11.13.2 Rentschler Biopharma SE Business Overview
11.13.3 Rentschler Biopharma SE Mammalian CDMO Service Introduction
11.13.4 Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2019-2024)
11.13.5 Rentschler Biopharma SE Recent Development
11.14 Northway Biotech
11.14.1 Northway Biotech Company Details
11.14.2 Northway Biotech Business Overview
11.14.3 Northway Biotech Mammalian CDMO Service Introduction
11.14.4 Northway Biotech Revenue in Mammalian CDMO Service Business (2019-2024)
11.14.5 Northway Biotech Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Details
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Mammalian CDMO Service Introduction
11.15.4 Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2019-2024)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Cambrex
11.16.1 Cambrex Company Details
11.16.2 Cambrex Business Overview
11.16.3 Cambrex Mammalian CDMO Service Introduction
11.16.4 Cambrex Revenue in Mammalian CDMO Service Business (2019-2024)
11.16.5 Cambrex Recent Development
11.17 FUJIFILM Diosynth Biotechnologies
11.17.1 FUJIFILM Diosynth Biotechnologies Company Details
11.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Introduction
11.17.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2019-2024)
11.17.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.18 GBI
11.18.1 GBI Company Details
11.18.2 GBI Business Overview
11.18.3 GBI Mammalian CDMO Service Introduction
11.18.4 GBI Revenue in Mammalian CDMO Service Business (2019-2024)
11.18.5 GBI Recent Development
11.19 Scorpius BioManufacturing
11.19.1 Scorpius BioManufacturing Company Details
11.19.2 Scorpius BioManufacturing Business Overview
11.19.3 Scorpius BioManufacturing Mammalian CDMO Service Introduction
11.19.4 Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2019-2024)
11.19.5 Scorpius BioManufacturing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
SAMSUNG
GTP
Cytovance Biologics
3P Bio
AGC Biologics
KBI Biopharma
GTP Bioways
Samsung Biologics
Wuxi Biologics
plantform corporation
Gedeon Richter
Lonza
Novartis
Rentschler Biopharma SE
Northway Biotech
Boehringer Ingelheim
Cambrex
FUJIFILM Diosynth Biotechnologies
GBI
Scorpius BioManufacturing
Tanvex CDMO
List of Tables
 Table 1. Global Mammalian CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Cell Line Development
 Table 3. Key Players of Genomic Analysis
 Table 4. Key Players of Process Development
 Table 5. Key Players of Analytical Services
 Table 6. Key Players of Formulation Development
 Table 7. Key Players of Manufacturing
 Table 8. Key Players of Others
 Table 9. Global Mammalian CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 10. Global Mammalian CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 11. Global Mammalian CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 12. Global Mammalian CDMO Service Market Share by Region (2019-2024)
 Table 13. Global Mammalian CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 14. Global Mammalian CDMO Service Market Share by Region (2025-2030)
 Table 15. Mammalian CDMO Service Market Trends
 Table 16. Mammalian CDMO Service Market Drivers
 Table 17. Mammalian CDMO Service Market Challenges
 Table 18. Mammalian CDMO Service Market Restraints
 Table 19. Global Mammalian CDMO Service Revenue by Players (2019-2024) & (US$ Million)
 Table 20. Global Mammalian CDMO Service Market Share by Players (2019-2024)
 Table 21. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2023)
 Table 22. Ranking of Global Top Mammalian CDMO Service Companies by Revenue (US$ Million) in 2023
 Table 23. Global 5 Largest Players Market Share by Mammalian CDMO Service Revenue (CR5 and HHI) & (2019-2024)
 Table 24. Global Key Players of Mammalian CDMO Service, Headquarters and Area Served
 Table 25. Global Key Players of Mammalian CDMO Service, Product and Application
 Table 26. Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Mammalian CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 29. Global Mammalian CDMO Service Revenue Market Share by Type (2019-2024)
 Table 30. Global Mammalian CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 31. Global Mammalian CDMO Service Revenue Market Share by Type (2025-2030)
 Table 32. Global Mammalian CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 33. Global Mammalian CDMO Service Revenue Market Share by Application (2019-2024)
 Table 34. Global Mammalian CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 35. Global Mammalian CDMO Service Revenue Market Share by Application (2025-2030)
 Table 36. North America Mammalian CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. North America Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 38. North America Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Europe Mammalian CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Europe Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 41. Europe Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 42. Asia-Pacific Mammalian CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Asia-Pacific Mammalian CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 44. Asia-Pacific Mammalian CDMO Service Market Size by Region (2025-2030) & (US$ Million)
 Table 45. Latin America Mammalian CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Latin America Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Latin America Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Middle East & Africa Mammalian CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 49. Middle East & Africa Mammalian CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 50. Middle East & Africa Mammalian CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 51. Cytovance Biologics Company Details
 Table 52. Cytovance Biologics Business Overview
 Table 53. Cytovance Biologics Mammalian CDMO Service Product
 Table 54. Cytovance Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 55. Cytovance Biologics Recent Development
 Table 56. 3P Bio Company Details
 Table 57. 3P Bio Business Overview
 Table 58. 3P Bio Mammalian CDMO Service Product
 Table 59. 3P Bio Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 60. 3P Bio Recent Development
 Table 61. AGC Biologics Company Details
 Table 62. AGC Biologics Business Overview
 Table 63. AGC Biologics Mammalian CDMO Service Product
 Table 64. AGC Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 65. AGC Biologics Recent Development
 Table 66. KBI Biopharma Company Details
 Table 67. KBI Biopharma Business Overview
 Table 68. KBI Biopharma Mammalian CDMO Service Product
 Table 69. KBI Biopharma Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 70. KBI Biopharma Recent Development
 Table 71. GTP Bioways Company Details
 Table 72. GTP Bioways Business Overview
 Table 73. GTP Bioways Mammalian CDMO Service Product
 Table 74. GTP Bioways Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 75. GTP Bioways Recent Development
 Table 76. Tanvex CDMO Company Details
 Table 77. Tanvex CDMO Business Overview
 Table 78. Tanvex CDMO Mammalian CDMO Service Product
 Table 79. Tanvex CDMO Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 80. Tanvex CDMO Recent Development
 Table 81. Samsung Biologics Company Details
 Table 82. Samsung Biologics Business Overview
 Table 83. Samsung Biologics Mammalian CDMO Service Product
 Table 84. Samsung Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 85. Samsung Biologics Recent Development
 Table 86. WuXi Biologics Company Details
 Table 87. WuXi Biologics Business Overview
 Table 88. WuXi Biologics Mammalian CDMO Service Product
 Table 89. WuXi Biologics Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 90. WuXi Biologics Recent Development
 Table 91. PlantForm Corporation Company Details
 Table 92. PlantForm Corporation Business Overview
 Table 93. PlantForm Corporation Mammalian CDMO Service Product
 Table 94. PlantForm Corporation Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 95. PlantForm Corporation Recent Development
 Table 96. Gedeon Richter Company Details
 Table 97. Gedeon Richter Business Overview
 Table 98. Gedeon Richter Mammalian CDMO Service Product
 Table 99. Gedeon Richter Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 100. Gedeon Richter Recent Development
 Table 101. Lonza Company Details
 Table 102. Lonza Business Overview
 Table 103. Lonza Mammalian CDMO Service Product
 Table 104. Lonza Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 105. Lonza Recent Development
 Table 106. Novartis Company Details
 Table 107. Novartis Business Overview
 Table 108. Novartis Mammalian CDMO Service Product
 Table 109. Novartis Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 110. Novartis Recent Development
 Table 111. Rentschler Biopharma SE Company Details
 Table 112. Rentschler Biopharma SE Business Overview
 Table 113. Rentschler Biopharma SE Mammalian CDMO Service Product
 Table 114. Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 115. Rentschler Biopharma SE Recent Development
 Table 116. Northway Biotech Company Details
 Table 117. Northway Biotech Business Overview
 Table 118. Northway Biotech Mammalian CDMO Service Product
 Table 119. Northway Biotech Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 120. Northway Biotech Recent Development
 Table 121. Boehringer Ingelheim Company Details
 Table 122. Boehringer Ingelheim Business Overview
 Table 123. Boehringer Ingelheim Mammalian CDMO Service Product
 Table 124. Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 125. Boehringer Ingelheim Recent Development
 Table 126. Cambrex Company Details
 Table 127. Cambrex Business Overview
 Table 128. Cambrex Mammalian CDMO Service Product
 Table 129. Cambrex Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 130. Cambrex Recent Development
 Table 131. FUJIFILM Diosynth Biotechnologies Company Details
 Table 132. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 133. FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Product
 Table 134. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 135. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 136. GBI Company Details
 Table 137. GBI Business Overview
 Table 138. GBI Mammalian CDMO Service Product
 Table 139. GBI Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 140. GBI Recent Development
 Table 141. Scorpius BioManufacturing Company Details
 Table 142. Scorpius BioManufacturing Business Overview
 Table 143. Scorpius BioManufacturing Mammalian CDMO Service Product
 Table 144. Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2019-2024) & (US$ Million)
 Table 145. Scorpius BioManufacturing Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Mammalian CDMO Service Picture
 Figure 2. Global Mammalian CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mammalian CDMO Service Market Share by Type: 2023 VS 2030
 Figure 4. Cell Line Development Features
 Figure 5. Genomic Analysis Features
 Figure 6. Process Development Features
 Figure 7. Analytical Services Features
 Figure 8. Formulation Development Features
 Figure 9. Manufacturing Features
 Figure 10. Others Features
 Figure 11. Global Mammalian CDMO Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 12. Global Mammalian CDMO Service Market Share by Application: 2023 VS 2030
 Figure 13. Contract Research Organizations (CROs) Case Studies
 Figure 14. Pharmaceutical Case Studies
 Figure 15. Biotechnology Companies Case Studies
 Figure 16. Government Agencies Case Studies
 Figure 17. Others Case Studies
 Figure 18. Mammalian CDMO Service Report Years Considered
 Figure 19. Global Mammalian CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 20. Global Mammalian CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 21. Global Mammalian CDMO Service Market Share by Region: 2023 VS 2030
 Figure 22. Global Mammalian CDMO Service Market Share by Players in 2023
 Figure 23. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2023)
 Figure 24. The Top 10 and 5 Players Market Share by Mammalian CDMO Service Revenue in 2023
 Figure 25. North America Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. North America Mammalian CDMO Service Market Share by Country (2019-2030)
 Figure 27. United States Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Canada Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Europe Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Europe Mammalian CDMO Service Market Share by Country (2019-2030)
 Figure 31. Germany Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. France Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. U.K. Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Italy Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Russia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Nordic Countries Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Asia-Pacific Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Asia-Pacific Mammalian CDMO Service Market Share by Region (2019-2030)
 Figure 39. China Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Japan Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. South Korea Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Latin America Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Latin America Mammalian CDMO Service Market Share by Country (2019-2030)
 Figure 47. Mexico Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Brazil Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Middle East & Africa Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Middle East & Africa Mammalian CDMO Service Market Share by Country (2019-2030)
 Figure 51. Turkey Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. UAE Mammalian CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Cytovance Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 55. 3P Bio Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 56. AGC Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 57. KBI Biopharma Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 58. GTP Bioways Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 59. Tanvex CDMO Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 60. Samsung Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 61. WuXi Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 62. PlantForm Corporation Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 63. Gedeon Richter Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 64. Lonza Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 65. Novartis Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 66. Rentschler Biopharma SE Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 67. Northway Biotech Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 68. Boehringer Ingelheim Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 69. Cambrex Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 70. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 71. GBI Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 72. Scorpius BioManufacturing Revenue Growth Rate in Mammalian CDMO Service Business (2019-2024)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Medical Device CDMO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microbial CDMO Service Market Research Report 2024
Global Cell Therapy CDMO Market Research Report 2025
Global Plasmid CDMO Services Market Research Report 2025
Global Cell and Gene Therapy CDMO Market Research Report 2024
Global Innovative Drug CDMO Market Research Report 2024
Global Biologics Clinical Manufacturing CDMO Service Market Research Report 2024
Global Small Molecule Innovator CDMO Market Research Report 2025
Global Gene Cell Therapy CDMO Market Research Report 2024
Intermediate CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Intermediate CDMO Market Research Report 2024
Global CMO and CDMO biotechnology Market Research Report 2024
Global Medical Device CDMO and CRO Market Research Report 2025
Global Exosome CDMO Market Research Report 2024
Global Chemical API CDMO Market Research Report 2024
Small Molecule CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibody and Recombinant Protein CDMO Market Research Report 2025
Packaging CDMO Market
Softgel CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasmid DNA CDMO Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions